Back to first-pass browser

First-pass extracted concept

hypoxia-inducible factors

Candidate: concept label2 source documents7 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

HIFs, HIF signaling, HIF-α

Extracted Explainers

What the tool is doing

HIFs are presented as central hypoxia-responsive regulators that help immune cells adapt to the hypoxic tumor microenvironment while also contributing to immune escape. The review highlights effects on metabolism and immune gene expression.

Source 2DOIPubMed

What problem it solves

This concept helps explain how low oxygen conditions reshape tumor immunity across multiple immune-cell classes. It provides a unifying mechanism for linking hypoxia to altered recognition and killing of cancer cells.

Source 2DOIPubMed

What it does not solve

The abstract does not resolve which specific HIF isoforms, targets, or interventions are best for each immune-cell subtype or tumor context.

Source 2DOIPubMed

Alternatives

The abstract does not name alternative master regulatory frameworks beyond HIF-centered signaling.

Source 2DOIPubMed

Evidence Snippets

Finally, we summarize therapeutic approaches targeting HIFs, including HIF stabilizers and HIF-2α-selective antagonists.
Evidence 1Source 1DOIPubMedprovenance
Hypoxic tumor microenvironment (TME) ... activates hypoxia‑inducible factors (HIFs) and their downstream signaling pathways ... HIFs are conducive to the adaptation of various immune cells to the hypoxic TME.
Evidence 2Source 2DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1mechanistic summarysupports2026Source 2DOIPubMed

Activation of HIF signaling can inhibit immune-cell development in some tumor environments and impair antigen recognition and killing, thereby assisting immune escape.

Quoted textsource-backed
Additionally, the activation of HIF signaling may also inhibit the development of immune cells in some tumor environments, affecting the antigen recognition and killing processes to assist cancer cells in immune escape.
Claim 2mechanistic summarysupports2026Source 2DOIPubMed

HIFs help various immune cells adapt to the hypoxic tumor microenvironment.

Quoted textsource-backed
HIFs are conducive to the adaptation of various immune cells to the hypoxic TME.
Claim 3mechanistic summarysupports2026Source 2DOIPubMed

HIF-α stability can regulate metabolism and directly regulate expression of immune genes.

Quoted textsource-backed
The stability of HIF‑α can regulate metabolism and directly regulate the expression of immune genes.
Claim 4mechanistic summarysupports2026Source 2DOIPubMed

Hypoxic tumor microenvironments activate HIF signaling pathways that facilitate tumor progression and immune escape.

Quoted textsource-backed
Hypoxic tumor microenvironment (TME) is a common occurrence in the development of solid tumors, which activates hypoxia‑inducible factors (HIFs) and their downstream signaling pathways in cancer cells to facilitate tumor progression and immune escape.
Claim 5review scopesupports2026Source 1DOIPubMed

The review argues that crosstalk among hypoxia, inflammation, and lipid metabolism in atherosclerosis is active and dynamic rather than a simple linear cause-and-effect relationship.

Claim 6therapeutic relevancesupports2026Source 1DOIPubMed

The review summarizes therapeutic approaches targeting HIF signaling, including HIF stabilizers and HIF-2α-selective antagonists.

Claim 7therapeutic summarysupports2026Source 2DOIPubMed

More comprehensive understanding of HIF signaling in immune cells may benefit cancer immunotherapy.

Quoted textsource-backed
Therefore, understanding the relationship between HIF signaling and immune cells more comprehensively may yield substantial benefits for the immunotherapy of various types of cancer.